alpha phellandrene has been researched along with Cancer Pain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Acha, BT; Almeida, FRC; Dias, WA; Dittz, D; Ferreira, PMP; Gomes, LDS; Leal, BS; Lopes, EM; Pinheiro-Neto, FR; Reis Filho, ACD; Rodrigues, DCDN; Silva, JDN | 1 |
1 other study(ies) available for alpha phellandrene and Cancer Pain
Article | Year |
---|---|
α-Phellandrene exhibits antinociceptive and tumor-reducing effects in a mouse model of oncologic pain.
Topics: Analgesics; Animals; Antineoplastic Agents; Cancer Pain; Cell Line, Tumor; Cell Proliferation; Cyclohexane Monoterpenes; Cytokines; Female; Glutathione; Inflammation Mediators; Lipid Peroxidation; Melanoma, Experimental; Mice; Pain Threshold; Sarcoma 180; Tumor Burden; Tumor Cells, Cultured | 2021 |